It is generally believed that the induction of the IGF-1 triggers kidney hypertrophy and mesangial cell ECM accumulation, eventually accelerating the progress of DN [72,73] through the regulation of PI3K/Akt and MAPK pathways [74,75]. This evidence concerns the gene AKT1 and liver dysplastic nodule.